SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, 2002.
  • 2
    Mulshine JL, Linnoila RI, Jensen SM, et al. National targets for the early detection of lung cancer. J Natl Cancer Inst Monogr. 1992; 13: 183190.
  • 3
    American Lung Association. Best practices and program services: trends in lung cancer morbidity and mortality. New York: American Lung Association, 2001.
  • 4
    FossellaFV, KomakiR, PutmanJB, editors. Lung cancer. New York: Springer-Verlag, 2003.
  • 5
    Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res. 2003; 63: 17271730.
  • 6
    Jiang F, Katz RL. Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol. 2002; 11: 4757.
  • 7
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
  • 8
    Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames: Iowa State University Press, 1980.
  • 9
    SAS Institute. SAS/STAT user's guide. Version 8. Cary, NC: SAS Institute, Inc., 1999.
  • 10
    Michelland S, Gazzeri S, Brambilla E, Robert-Nicoud M. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas. Cancer Genet Cytogenet. 1999; 114: 2230.
  • 11
    Feder M, Siegfried JM, Balshem A, et al. Clinical relevance of chromosome abnormalities in non-small cell lung cancer. Cancer Genet Cytogenet. 1998; 102: 2531.
  • 12
    Taguchi T, Zhou JY, Feder M, Litwin S, Klein-Szanto AJ, Testa JR. Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes. Cancer Genet Cytogenet. 1996; 89: 120125.
  • 13
    Kubokura H, Tenjin T, Akiyama H, et al. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization. Ann Thorac Cardiovasc Surg. 2001; 7: 197203.
  • 14
    Romeo MS, Sokolova IA, Morrison LE, et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn. 2003; 5: 103112.
  • 15
    Testa JR, Siegfield JM. Chromosomal abnormalities in human non-small cell cancer. Cancer Res. 1992; 52(9 Suppl. ): 2702s2706s.
  • 16
    Ried T, Petersen I, Holtgreve-Grez H, et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 1994; 54: 18011806.
  • 17
    Taubald A, Liehr T, Ries J, Girod S, Hassfurter E, Gebhart E. CGH detected DNA sequence copy number amplifications can be confirmed by interphase-FISH: new possibilities for prognostic approaches in oral squamous carcinomas. Int J Mol Med. 1998; 2: 555560.
  • 18
    Taguchi T, Cheng GZ, Bell DW, et al. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line. Genes Chromosomes Cancer. 1997; 20: 208212.
  • 19
    Gazdar AF, Minna JD. Molecular detection of early lung cancer. J Natl Cancer Inst. 1999; 91: 299301.
  • 20
    Lilloglou T, Mahoney P, Xinaranos G, et al. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res. 2001; 61: 13091313.
  • 21
    Sanchez-Cespedes M, Ahrent SA, Piantadosi S, et al. Chromosomal alteration in lung adenocarcinoma from smokers and nonsmokers. Cancer Res. 2001; 61: 13091313.
  • 22
    Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer. 2002; 96: 306315.
  • 23
    McCarthy PM, Jelsing NC. An advocacy perspective on screening and early diagnosis of lung cancer. Cancer. 2000; 89: 25102514.
  • 24
    Tockman MS. Advances in sputum analysis for screening and early detection of lung cancer. Cancer Control. 2000; 7: 1924.
  • 25
    Schenk T, Ackermann J, Brunner C, et al. Detection of chromosomal aneuploidy by interphase in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest. 1997; 111: 16911696.
  • 26
    Stamouli MI, Ferti AD, Panani AD, et al. Application of multiplex fluorescence in situ hybridization in the cytogenetic analysis of primary gastric carcinoma. Cancer Genet Cytogenet. 2002; 135: 2327.
  • 27
    Fuller CE, Perry A. Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology. Brain Pathol. 2002; 12: 6786.
  • 28
    Dalquen P, Kleiber B, Grilli B, Herzog M, Bubendorf L, Oberholzer M. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine. Cancer. 2002; 96: 374379.
  • 29
    Engel H, Friedrich J, Kleespies C, et al. Detection of chromosomal aberrations in tumor cells and tumor infiltrating lymphocytes by molecular cytogenetics in patients with gynecological cancer. Cancer Genet Cytogenet. 1998; 106: 159165.
  • 30
    Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002; 21: 69156935.
  • 31
    Khubchandani KR, Snyder JM. Surfactant protein a (SP-A): the alveolus and beyond. FASEB J. 2001; 15: 5969.
  • 32
    Petersen S, Aninat-Meyer M, Schluns K, Gellert K, Dietel M, Petersen I. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer. 2000; 82: 6573.
  • 33
    Petersen S, Wolf G, Bockmuhl U, Gellert K, Dietel M, Petersen I. Allelic loss on chromosome 10q in human lung cancer: association with tumor progression and metastatic phenotype. Br J Cancer. 1998; 77: 270276.
  • 34
    Piyathilake CJ, Frost AR, Manne U, et al. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res. 2002; 8: 734744.
  • 35
    Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998; 90: 11981205.
  • 36
    Brabender J, Danenberg KD, Metzger R, et al. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival. Clin Cancer Res. 2001; 7: 18501855.